T-type Ca(2+) channel modulation by otilonium bromide

Area of Science:

• Pharmacology
• Molecular Biology
• Gastroenterology

Background:

• Antispasmodics manage gastrointestinal disorders by inhibiting smooth muscle contraction.
• L-type calcium channels are primary regulators of smooth muscle contraction, but T-type calcium channels also play a role.
• Otilonium bromide is an antispasmodic known to inhibit L-type calcium channels and colonic contractility.

Purpose of the Study:

• To investigate whether otilonium bromide also inhibits T-type calcium channels.
• To explore a potential new mechanism of action for antispasmodics.

Main Methods:

• Patch-clamp technique was used to record whole-cell currents.
• HEK293 cells expressing T-type calcium channel alpha subunits (CaV3.1, CaV3.2, CaV3.3) were utilized.
• Cells were exposed to varying concentrations of otilonium bromide (10⁻⁸ to 10⁻⁵ M).

Main Results:

• Otilonium bromide demonstrated reversible inhibition of all tested T-type calcium channels (CaV3.1, CaV3.2, CaV3.3).
• The drug exhibited a higher affinity for CaV3.3 compared to CaV3.1 and CaV3.2.
• Otilonium bromide also slowed the inactivation of CaV3.1 and CaV3.3 channels.

Conclusions:

• Inhibition of T-type calcium channels by otilonium bromide may contribute to its antispasmodic effect.
• This action on T-type channels represents a novel mechanism for antispasmodics.
• This finding could explain the enhanced clinical efficacy of otilonium bromide compared to selective L-type channel blockers.